Loading
HU
HUM Stock: price and insider trades · Australia
HUM: what insiders have been doing
HUM, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 17 October 2026, 4 filings were filed, from 3 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of HUM has been absent for the past year.
Compared with its exchange (2,222 companies, median 3 filings), a count of 4 filings is above the norm.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate HUM Strong Buy (bullish), based on 2 analysts. Average price target: A$0.80.
Fundamental score
Ranked 9,659 of 24,148 companies
56.6
score / 100
Value70
Quality44
FCF yld32%
Earn yld7.2%
EV/EBITDA14.7x
ROE3.0%
Gross mgn96%
Net mgn2.5%
Debt/EBITDA14.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
A$0.43
Analyst consensus
2 analystsStrong buy
A$0.75Target A$0.80(+86%)A$0.85
Income statement
RevenueA$623.3M
Gross profitA$596.9M96% margin
EBITDAA$318.4M51% margin
Net incomeA$15.7M6.2% margin
Valuation
PER (trailing)14.3x
PER (forward)4.2x
P/Book0.4x
Beta1.60
Balance sheet & cash
Market capA$217.1M
Total debtA$4.5B
Free Cash FlowA$69.5M
Debt / Equity832%
Profitability & ownership
ROE3.0%
ROA0.3%
% insiders46.0%
% institutions18.1%
Last declaration on 14 May 2026
Declarations4 total
ShareASXASX:2924-03090173-2A1672112
ShareASXASX:2924-03090172-2A1672111
ShareASXASX:2924-03090146-2A1672095
ShareASXASX:2924-03090145-2A1672094
4 of 4 declarations
About HUM
HUM is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions to improve patient health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
